Dxcover Limited: Dxcover to Present New Data on Liquid Biopsy Platform at the 2023 American Association for Cancer Research (AACR) Annual Meeting
Dxcover Limited, a clinical-stage diagnostics company developing spectroscopic liquid biopsy technology for early detection of multiple cancers, today announced the upcoming presentation of new data